YORK MEDICAL GROUP
199 ACOMB ROAD, YORK
CKD 5
The percentage of patients on the CKD register with hypertension and proteinuria who are treated with an angiotensin coverting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (AEB) (unless a contraindication or side effects are recorded)
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| CKD 4 | 2007 | 206 | 234 | 88.0% | |
| CKD 4 | 2008 | 221 | 243 | 90.9% | |
| CKD 5 | 2009 | 66 | 73 | 90.4% | |
| CKD 5 | 2010 | 13 | 15 | 86.7% | |
| CKD 5 | 2011 | 15 | 16 | 93.8% | |
| CKD 5 | 2012 | 17 | 18 | 94.4% | |
| CKD 5 | 2013 | 18 | 18 | 100.0% | |
| CKD003 | 2014 | 12 | 12 | 100.0% | |
| CKD003 | 2015 | 73 | 86 | 84.9% | |
| NM84 | 2016 | 62 | 87 | 71.3% | |
| NM84 | 2019 | 56 | 85 | 65.9% | |
| NM84 | 2020 | 54 | 93 | 58.1% | |
| NM84 | 2022 | 53 | 88 | 60.2% | |
| NM84 | 2023 | 62 | 90 | 68.9% |
